Mental Retardation News and Research

RSS

Inhaled nitric oxide safe for very premature infants

A nationwide study led by researchers at UCSF provides evidence that inhaled nitric oxide is safe and effective for the prevention of the most common type of long-term lung disease of very premature infants.

7 Aug 2007

Scientists discover brain cell development process implicated in mental retardation

New Brunswick, N.J. , Scientists at Rutgers, The State University of New Jersey, have discovered a biological process in brain cell development that may help explain some causes of mental retardation.

1 Aug 2007

Report reveals pregnancies exposed to accutane despite iPledge

Despite a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), 122 pregnancies were exposed during the first year of the program, known as iPledge, a report revealed.

1 Aug 2007

New understanding of Sly Syndrome

The scientist who discovered “Sly Syndrome” nearly four decades ago and a team of colleagues at Saint Louis University are a step closer to finding an approach to treat the rare genetic disease.

26 Jul 2007

ACMG recognizes progress made in newborn screening

In support of the latest March of Dimes Newborn Screening Report Card, the American College of Medical Genetics (ACMG) strongly urges every state to require complete testing of all newborns for a 'core panel' of genetic and congenital conditions.

16 Jul 2007

Simple blood test for newborns would save lives

The president of the March of Dimes Dr. Jennifer Howse says a simple blood test could save many newborns from premature death or mental retardation.

12 Jul 2007

Scientists discover protein instrumental to brain development and repair

Scientists at Children's National Medical Center have demonstrated conclusively that a specific protein and its signaling activity are instrumental in myelination and remyelination, processes essential to the creation and repair of the brain's white matter.

9 Jul 2007

Hib vaccine could save hundreds of thousands of children in Asia

A new study from Bangladesh published online in The Pediatric Infectious Disease Journal shows that routinely vaccinating infants against H. influenzae type b (Hib), a bacterium that causes deadly Hib pneumonia and meningitis, could save hundreds of thousands of children in Asia.

28 Jun 2007

Autism reversed in mice

Scientists in the United States have been able to reverse the effects of autism in specially bred mice.

26 Jun 2007

Scoliosis gene found

Physicians have recognized scoliosis, the abnormal curvature of the spine, since the time of Hippocrates, but its causes have remained a mystery -- until now. For the first time, researchers have discovered a gene that underlies the condition, which affects about 3 percent of all children.

26 Jun 2007

MIT researchers reverse behavioral symptoms in mice

Researchers at the Picower Institute for Learning and Memory at MIT have, for the first time, reversed symptoms of mental retardation and autism in mice.

26 Jun 2007

Basically eating fish may protect against type of blindness

Increasing intake of the omega-3 fatty acids DHA and EPA, found in popular fish-oil supplements, may protect against blindness resulting from abnormal blood vessel growth in the eye, according to a study published online by the journal Nature Medicine on June 24.

26 Jun 2007

Vaccine for human cytomegalovirus

Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.

23 Jun 2007

Goltz syndrome gene found

Researchers funded in part by the National Institutes of Health have identified the gene that accounts for most cases of Goltz syndrome, a rare skin disorder that can also affect bone and eye development.

23 Jun 2007

New data on the performance of meningitis vaccine in West African children

The Meningitis Vaccine Project (MVP) today released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine,expected to sell initially for 40 US cents a dose,will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.

14 Jun 2007

New vaccine promises end of devastating meningitis epidemics in Africa

Scientists are optimistic that a new meningitis vaccine will end the risk of devastating major epidemics; the new vaccine protects against meningitis A, the deadliest form of the disease.

11 Jun 2007

New target for the Fragile X mental retardation protein

Researchers in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine have identified a new regulatory target for the Fragile X mental retardation protein (FMRP), laying the groundwork for possible new treatments for Fragile X syndrome(FXS), the leading inherited form of mental retardation.

8 Jun 2007